Get started

Stocktowatch

NSE:Lupin -trend change on card??? NSE:LUPIN Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, dialectology, asthma, paediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One, V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others. Disc: Invested, please do you own research
NSE:LUPIN
by Peaceful-Weekend-Investing
V-Gaurd Industries taking a guard for Positive Break outV- guard industries based in Kochi; Kerala is a multi-product company catering to the mass consumption market. The Company is engaged in manufacturing, trading and selling of a wide range of Electronics, Electrical and Consumer Durables. Over the years V-Guard has sold into domestic, industrial and agricultural electronic goods and appliances category. V-Guard operates more than 10 plants across various geographies across India manufacturing multiple categories. V- guard industries Limited CMP is 299.90. The Negative aspects of the company are High Valuation (P.E. = 65), declining annual net profit, FIIs are decreasing stake and promoter Holding decreasing. The positive aspects of the company are Low debt, zero promoter pledge, MFs are increasing stake and improving cash from operations annual. Entry after closing above 304. Targets in the stock will be 312 and 324. Long term targets in the stock will be 335+. Stop loss in the stock should be maintained at closing below 281. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:VGUARDLong
by Happy_Candles_Investment
Trying to make a bottom Dr.Reddy's LabDr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products. Dr Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA).Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy Limited CMP is 5478. The Negative aspects of the company are FIIs are decreasing stake, MFs are decreasing stake and Promoter Holding decreasing. The positive aspects of the company are No debt, zero promoter pledge, improving annual net profit and improving cash from operations. Entry after closing above 5527. Targets in the stock will be 5642 and 5567. Long term targets in the stock will be 5847 and 5992. Stop loss in the stock should be maintained at closing below 5270. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:DRREDDYLong
by Happy_Candles_Investment
Apex Frozen Foods Ltd (Apex) 🫳🏿 time now ??? Apex Frozen Foods Ltd (Apex) is an integrated producer and exporter of processed shrimps based in Andhra Pradesh, South India. The company has a capacity of 29,240MT. In Q3-FY23, Apex experienced a 1% year-on-year decline in revenue due to reduced demand in key export markets such as the US and EU, as well as a supply shortage of specific-size raw materials. Despite the decline in export prices, the company managed to maintain stable realisation year-on-year, helped by rupee depreciation. This is because the decrease in the export price in dollars was offset by the depreciation of the rupee. Apex's future growth will be driven by its backward integration (hatchery), an increase in the newly-added capacity, and a larger contribution from value-added products. The company has expanded its ready-to-eat (RTE) capacity from 5,000MT to 10,000MT and anticipates starting commercial production in Q4-FY23. Apex is currently awaiting approval to sell RTE products from the new capacity in the European market. Europe currently contributes to only 18% of total revenue. The company's earnings are expected to grow at a 45% Compound Annual Growth Rate (CAGR) over FY22-24. Apex is currently trading at 9x 1Yr Forward Price to Earnings (Fwd P/E). The company is valued at 10x (3Yr Average=10x) on FY24 Earnings Per Share (EPS) disc: Invested , first trance taken
NSE:APEXLong
by Peaceful-Weekend-Investing